This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Talk:Perampanel: Difference between revisions
>Fycompah21 Adding content |
>David Hedlund {{Experience reports|erowid_experience_substance_label=}} |
||
| (One intermediate revision by one other user not shown) | |||
| Line 7: | Line 7: | ||
<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on substance XYZ should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. --> | <!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on substance XYZ should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. --> | ||
Perampanel (also known as Fycompa) is a synthetic non-competitive antagonist of the AMPA receptor, belonging to the class of dissociatives and categorized as an anticonvulsant | Perampanel (also known as Fycompa) is a synthetic non-competitive antagonist of the AMPA receptor, belonging to the class of dissociatives and categorized as an anticonvulsant | ||
| Line 94: | Line 92: | ||
}} | }} | ||
===Experience reports=== | ===Experience reports=== | ||
{{Experience reports| | {{Experience reports|erowid_experience_substance_label=}} | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||